Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maves vs Rivo Health

Maves
Graded #89

Higher grade

vs+0.09999999999999432
Rivo Health
Graded #90

Lower grade

The verdict

Maves takes it — 71.8/100 to 71.7/100, but only just.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with… Rivo Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +10
84
74
Dose & formulationRivo Health +10
65
75
Clinical oversightRivo Health +1
76
77
Labs & monitoringRivo Health +11
52
63
FulfillmentMaves +3
87
84
Contract termsMaves +14
55
41
Maves · left barRivo Health · right bar

The numbers

MetricMavesRivo Health
WeighScore71.8/10071.7/100
GradeCC
Scorecard rank#89#90
Semaglutide$99/mo (starting dose, first-month rate, compounded)$149/mo (compounded)
TirzepatideNot disclosed$199/mo (compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Maves

Graded #89 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed
Rivo Health

Graded #90 · C

Strengths

  • Compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo (sema) and $199/mo (tirz)
  • Bundles dietitians, live workouts, support groups and mental-health coaching with the medication, not just a prescription
  • Insurance concierge to maximize coverage, FSA/HSA eligible, with multi-month plans that cut the price further
  • Large, established program (115,000+ members, Trustpilot 4.7) available nationwide

Where it loses points

  • Uses partner compounding pharmacies it doesn't name on the site
  • Headline prices are Spring-sale rates — everyday cost is higher and the deepest discounts need a 6-month commitment
  • Weight loss is one of several verticals (ED, longevity, sleep, hair, skin), not a single focus
  • Some bundled perks (e.g. meal prep) are paid add-ons rather than included

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard